{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:03:25Z","timestamp":1792634605775,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Science Centre DEC","award":["2012\/05\/B\/NZ7\/02705"],"award-info":[{"award-number":["2012\/05\/B\/NZ7\/02705"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.pbb.2013.06.013","type":"journal-article","created":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T03:32:30Z","timestamp":1373427150000},"page":"145-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Evaluation of anxiolytic-like, anticonvulsant, antidepressant-like and antinociceptive properties of new 2-substituted 4-hydroxybutanamides with affinity for GABA transporters in mice"],"prefix":"10.1016","volume":"110","author":[{"given":"Kinga","family":"Sa\u0142at","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Kulig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Gajda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Wi\u0119ckowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Filipek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Malawska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2013.06.013_bb0005","first-page":"81","article-title":"A new simple method to explore the tranquilizing action: the chimney test","volume":"3","author":"Boissier","year":"1960","journal-title":"Med Exp"},{"key":"10.1016\/j.pbb.2013.06.013_bb0015","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.pbb.2005.04.015","article-title":"Anxiolytic-like effect of milnacipran in the four-plate test in mice: mechanism of action","volume":"81","author":"Bourin","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"issue":"8","key":"10.1016\/j.pbb.2013.06.013_bb0010","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/sj.mp.4001362","article-title":"GABAergic dysfunction in mood disorders","volume":"8","author":"Brambilla","year":"2003","journal-title":"Mol Psychiatry"},{"issue":"2","key":"10.1016\/j.pbb.2013.06.013_bb0020","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/jnr.20884","article-title":"Mice with genetically altered GABA transporter subtype I (GAT1) expression show altered behavioral responses to ethanol","volume":"84","author":"Cai","year":"2006","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pbb.2013.06.013_bb0025","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1734-1140(09)70137-9","article-title":"Effect of caffeine on anticonvulsant effects of oxcarbazepine, lamotrigine and tiagabine in a mouse model of generalized tonic\u2013clonic seizures","volume":"61","author":"Chroscinska-Krawczyk","year":"2009","journal-title":"Pharmacol Rep"},{"issue":"6\u20137","key":"10.1016\/j.pbb.2013.06.013_bb0030","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.neuint.2005.12.031","article-title":"A novel selective gamma-aminobutyric acid transport inhibitor demonstrates a functional role for GABA transporter subtype GAT2\/BGT-1 in the CNS","volume":"48","author":"Clausen","year":"2006","journal-title":"Neurochem Int"},{"issue":"3","key":"10.1016\/j.pbb.2013.06.013_bb0035","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.brainresrev.2004.03.003","article-title":"GABA transporters in the mammalian cerebral cortex: localization, development and pathological implications","volume":"45","author":"Conti","year":"2004","journal-title":"Brain Res Brain Res Rev"},{"issue":"12","key":"10.1016\/j.pbb.2013.06.013_bb0045","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/S0028-3908(00)00075-7","article-title":"GABA-level increasing and anticonvulsant effects of three different GABA uptake inhibitors","volume":"39","author":"Dalby","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2013.06.013_bb0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejphar.2003.08.063","article-title":"Inhibition of \u03b3-aminobutyric acid uptake: anatomy, physiology and effects against epileptic seizures","volume":"479","author":"Dalby","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2013.06.013_bb0040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0920-1211(97)00033-8","article-title":"Anticonvulsant properties of two GABA uptake inhibitors NNC 05-2045 and NNC 05-2090, not acting preferentially on GAT-1","volume":"28","author":"Dalby","year":"1997","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pbb.2013.06.013_bb0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2008.12.046","article-title":"Pharmacodynamic and pharmacokinetic interaction profile of levetiracetam in combination with gabapentin, tiagabine and vigabatrin in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis","volume":"605","author":"Dudra-Jastrzebska","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2013.06.013_bb0060","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0022-3565(25)05180-8","article-title":"Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines","volume":"107","author":"Eddy","year":"1953","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.pbb.2013.06.013_bb0065","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.3390\/ijms13032578","article-title":"Inhibitory action of antidepressants on mouse betaine\/GABA transporter (BGT1) heterologously expressed in cell cultures","volume":"13","author":"Gerile","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pbb.2013.06.013_bb0070","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejphar.2006.09.042","article-title":"Anxiolytic-like activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone","volume":"553","author":"Harada","year":"2006","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.pbb.2013.06.013_bb0085","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/jnr.10677","article-title":"Hyperalgesic effects of gamma-aminobutyric acid transporter I in mice","volume":"73","author":"Hu","year":"2003","journal-title":"J Neurosci Res"},{"issue":"4","key":"10.1016\/j.pbb.2013.06.013_bb0080","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.neuroscience.2003.11.018","article-title":"Up-regulation of gamma-aminobutyric acid transporter I mediates ethanol sensitivity in mice","volume":"123","author":"Hu","year":"2004","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.pbb.2013.06.013_bb0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0304-3959(87)90088-1","article-title":"The formalin test in mice: dissociation between inflammatory and non-inflammatory pain","volume":"30","author":"Hunskaar","year":"1987","journal-title":"Pain"},{"issue":"2\u20133","key":"10.1016\/j.pbb.2013.06.013_bb0095","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0014-2999(99)00034-5","article-title":"Tiagabine antinociception in rodents depends on GABA(B) receptor activation: parallel antinociception testing and medial thalamus GABA microdialysis","volume":"368","author":"Ipponi","year":"1999","journal-title":"Eur J Pharmacol"},{"issue":"1\u20132","key":"10.1016\/j.pbb.2013.06.013_bb0100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0169-328X(95)00342-P","article-title":"Neuronal and glial localization of two GABA transporters (GAT1 and GAT3) in the rat cerebellum","volume":"37","author":"Itouji","year":"1996","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.pbb.2013.06.013_bb0105","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1016\/j.ejmech.2008.01.005","article-title":"Synthesis and biological evaluation of aminomethylphenol derivatives as inhibitors of the murine GABA transporters mGAT1\u2013mGAT4","volume":"43","author":"Kragler","year":"2008","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pbb.2013.06.013_bb0110","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejmech.2010.11.001","article-title":"Synthesis and biological evaluation of the new amides of 2-substituted 4-hydroxybutyric acid derivatives as GABA uptake inhibitors","volume":"46","author":"Kulig","year":"2011","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.pbb.2013.06.013_bb0115","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1124\/jpet.302.3.1168","article-title":"Comparison of antiepileptic drugs tiagabine, lamotrigine, and gabapentin in mouse models of acute, prolonged and chronic nociception","volume":"302","author":"Laughlin","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2013.06.013_bb0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(25)03549-9","article-title":"A simplified method of evaluating dose\u2013effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.pbb.2013.06.013_bb0125","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/jnr.21148","article-title":"Reduced aggression in mice lacking GABA transporter subtype 1","volume":"85","author":"Liu","year":"2007","journal-title":"J Neurosci Res"},{"issue":"2","key":"10.1016\/j.pbb.2013.06.013_bb0130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0920-1211(91)90075-Q","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models","volume":"8","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Res"},{"issue":"3","key":"10.1016\/j.pbb.2013.06.013_bb0135","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.pharmthera.2009.11.007","article-title":"Neuronal and non-neuronal GABA transporters as targets for antiepileptic drugs","volume":"125","author":"Madsen","year":"2010","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.pbb.2013.06.013_bb0140","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.nurt.2006.11.010","article-title":"Molecular targets for antiepileptic drug development","volume":"4","author":"Meldrum","year":"2007","journal-title":"Neurotherapeutics"},{"issue":"2","key":"10.1016\/j.pbb.2013.06.013_bb0150","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.pbb.2013.06.013_bb0155","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4155\/fmc.10.298","article-title":"GABA transporters as targets for new drugs","volume":"3","author":"Salat","year":"2011","journal-title":"Future Med Chem"},{"issue":"1","key":"10.1016\/j.pbb.2013.06.013_bb0160","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S1734-1140(12)70736-3","article-title":"Analgesic and anticonvulsant activity of new derivatives of 2-substituted 4-hydroxybutanamides in mice","volume":"64","author":"Sa\u0142at","year":"2012","journal-title":"Pharmacol Rep"},{"issue":"4","key":"10.1016\/j.pbb.2013.06.013_bb0165","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1734-1140(12)70877-0","article-title":"Synthesis and pharmacological properties of new GABA uptake inhibitors","volume":"64","author":"Sa\u0142at","year":"2012","journal-title":"Pharmacol Rep"},{"issue":"6","key":"10.1016\/j.pbb.2013.06.013_bb0170","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00210-013-0847-2","article-title":"Evaluation of antinociceptive and antioxidant properties of 3-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one in mice","volume":"386","author":"Sa\u0142at","year":"2013","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"4","key":"10.1016\/j.pbb.2013.06.013_bb0175","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2174\/1568007033482788","article-title":"GABA transporters and GABA-transaminase as drug targets","volume":"2","author":"Sarup","year":"2003","journal-title":"Curr Drug Targets CNS Neurol Disord"},{"issue":"45","key":"10.1016\/j.pbb.2013.06.013_bb0180","doi-asserted-by":"crossref","first-page":"37745","DOI":"10.1074\/jbc.M112.388157","article-title":"High selectivity of the \u03b3-aminobutyric acid transporter 2 (GAT-2, SLC6A13) revealed by structure-based approach","volume":"287","author":"Schlessinger","year":"2012","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.pbb.2013.06.013_bb0190","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00008877-199903000-00002","article-title":"Effects of GABA-transporter (GAT) inhibitors on rat behaviour in open-field and elevated plus-maze","volume":"10","author":"Schmitt","year":"1999","journal-title":"Behav Pharmacol"},{"issue":"5\u20136","key":"10.1016\/j.pbb.2013.06.013_bb0185","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s007020200071","article-title":"Anxiolytic-like effects of acute and chronic GABA transporter inhibition in rats","volume":"109","author":"Schmitt","year":"2002","journal-title":"J Neural Transm"},{"issue":"1\u20133","key":"10.1016\/j.pbb.2013.06.013_bb0195","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ejphar.2004.07.032","article-title":"Role of the betaine\/GABA transporter (BGT-1\/GAT2) for the control of epilepsy","volume":"500","author":"Schousboe","year":"2004","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"10.1016\/j.pbb.2013.06.013_bb0200","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2174\/0929867003374363","article-title":"The GABA transporter and its inhibitors","volume":"7","author":"Soudijn","year":"2000","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pbb.2013.06.013_bb0205","first-page":"733","article-title":"Long-term anxiolytic and antidepressant-like behavioural effects of tiagabine, a selective GABA transporter-1 (GAT-1) inhibitor, coincide with a decrease in HPA system activity in C57BL\/6 mice","volume":"24","author":"Thoeringer","year":"2010","journal-title":"J Pharmacol"},{"issue":"1","key":"10.1016\/j.pbb.2013.06.013_bb0210","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3959(92)90003-T","article-title":"The formalin test: an evaluation of the method","volume":"51","author":"Tj\u00f8lsen","year":"1992","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.pbb.2013.06.013_bb0215","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/01.ajp.0000110637.14355.77","article-title":"Tiagabine and gabapentin for the management of chronic pain","volume":"21","author":"Todorov","year":"2005","journal-title":"Clin J Pain"},{"issue":"2","key":"10.1016\/j.pbb.2013.06.013_bb0220","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1124\/jpet.104.068825","article-title":"First demonstration of a functional role for central nervous system betaine\/{gamma}-aminobutyric acid transporter (mGAT2) based on synergistic anticonvulsant action among inhibitors of mGAT1 and mGAT2","volume":"312","author":"White","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2013.06.013_bb0225","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1124\/jpet.102.047902","article-title":"The heritability of antinociception II: pharmacogenetic mediation of three over-the-counter analgesics in mice","volume":"305","author":"Wilson","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.pbb.2013.06.013_bb0230","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/jnr.21499","article-title":"Hypoalgesia in mice lacking GABA transporter subtype 1","volume":"86","author":"Xu","year":"2008","journal-title":"J Neurosci Res"},{"issue":"1","key":"10.1016\/j.pbb.2013.06.013_bb0235","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1090-3801(98)90047-7","article-title":"Influence of formalin concentration on the antinociceptive effects of anti-inflammatory drugs in the formalin test in rats: separate mechanisms underlying the nociceptive effects of low- and high-concentration formalin","volume":"2","author":"Yashpal","year":"1998","journal-title":"Eur J Pain"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305713001706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305713001706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T13:02:01Z","timestamp":1746018121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305713001706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":45,"alternative-id":["S0091305713001706"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2013.06.013","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of anxiolytic-like, anticonvulsant, antidepressant-like and antinociceptive properties of new 2-substituted 4-hydroxybutanamides with affinity for GABA transporters in mice","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2013.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}